Skip to main content
Equibles

Thrivent Financial for Lutherans

Position in VIR — Vir Biotechnology, Inc.

CIK 314984 Minneapolis, MN
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,348,523
+$330,731 QoQ
Shares Held
132,338
+16.5% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 237 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $496,588,000 across 51 Biotechnology names. VIR ranks #29 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TWST
Twist Bioscience Corp
 1,433,503 $147,478,787
2 EXEL
Exelixis, Inc.
 1,620,743 $88,184,625
3 REGN
Regeneron Pharmaceuticals, Inc.
 131,457 $81,968,697
4 RPRX
Royalty Pharma plc
 740,772 $41,535,085
5 JAZZ
Jazz Pharmaceuticals plc
 80,500 $19,398,084
6 ARGX
Argenx SE
 12,688 $11,771,545
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,169 $10,018,546
8 VCEL
Vericel Corp
 170,272 $7,575,400

All Filings in VIR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,348,523 132,338
2026-03-31 $1,017,792 113,593
2025-12-31 $391,986 65,006
2025-09-30 $389,130 68,149
2025-06-30 $343,249 68,105
2025-03-31 $439,188 67,776
2024-12-31 $523,503 71,322
2024-09-30 $538,471 71,892
2024-06-30 $643,354 72,287
2024-03-31 $756,589 74,688
2023-12-31 $771,762 76,716
2023-09-30 $736,482 78,600
2023-06-30 $1,792,039 73,055
2023-03-31 $1,749,764 75,194
2022-12-31 $1,969,877 77,830
2022-09-30 $1,506,789 78,153
2022-06-30 $1,854,980 72,830